Back to User profile » Dr Michael Keng

Papers published by Dr Michael Keng:

Review

Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions

Varadarajan I, Pierce E, Scheuing L, Morris A, El Chaer F, Keng M

OncoTargets and Therapy 2023, 16:1-16

Published Date: 14 January 2023

Original Research

A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate

Reed DR, Pierce EJ, Sen JM, Keng MK

Cancer Management and Research 2019, 11:8065-8072

Published Date: 30 August 2019

Review

Enasidenib in acute myeloid leukemia: clinical development and perspectives on treatment

Reed DR, Elsarrag RZ, Morris AL, Keng MK

Cancer Management and Research 2019, 11:8073-8080

Published Date: 30 August 2019

Review

Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date

Hathaway L, Sen JM, Keng M

Patient Related Outcome Measures 2018, 9:329-337

Published Date: 2 October 2018